PRMT6 and glioblastoma: At the protein level in the CPTAC proteomics database, PRMT6 and YTHDF2 also demonstrated a strong positive correlation in GBM patients (Fig. 3D), with lower correlations with other YTH domain family molecules (Supplementary Material 2: Fig. S2C), suggesting a potential influence of PRMT6 on YTHDF2 expression.